Related Experiment Videos
Insulin and IGF-1 binding in chick sclera.
R J Waldbillig1, D R Arnold, R T Fletcher
1Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892.
Investigative Ophthalmology & Visual Science
|June 1, 1990
Summary
Insulin and insulin-like growth factor-1 (IGF-1) binding sites in chick sclera decrease with development. This reduction is due to fewer binding sites, not altered affinity, indicating developmental regulation of these growth factor receptors.
Area of Science:
- Ophthalmology
- Developmental Biology
- Endocrinology
Background:
- The sclera, the eye's protective outer layer, plays a role in ocular development.
- Insulin and insulin-like growth factor-1 (IGF-1) are crucial for growth and development.
- Understanding growth factor signaling in the sclera is key to comprehending ocular development.
Purpose of the Study:
- To investigate the presence and characteristics of insulin and IGF-1 binding sites in embryonic and young adult chick sclera.
- To determine how these binding sites change during development and their specificity.
Main Methods:
- Radioligand binding assays were used to quantify insulin and IGF-1 binding in scleral tissue.
- Competition assays were performed to assess the specificity of the binding sites for insulin and IGF-1.
- Analysis of binding site characteristics across different developmental stages (embryonic vs. posthatching).
Main Results:
- Distinct binding sites for insulin and IGF-1 were identified in chick sclera.
- A significant decrease (nearly 50%) in both insulin and IGF-1 binding was observed between embryonic and young adult stages.
- Binding site affinity remained stable, suggesting a decrease in the number of sites during development.
- Specific IGF-1 binding sites showed improved specificity in young adults compared to embryonic stages.
Conclusions:
- Insulin and IGF-1 binding sites in the chick sclera are developmentally regulated, with numbers decreasing post-hatching.
- The observed decrease in binding is attributed to a reduction in the quantity of binding sites, not a change in their affinity.
- These findings highlight the dynamic role of insulin and IGF-1 signaling in scleral development and ocular growth.